Skip to main content
BLCO logo

Bausch + Lomb Corporation

BLCONYSEHealthcareMedical Instruments & Supplies

$17.43Today:- (-)1Y +10.46%

As of Oct 22, 2026 close

Market cap
$6.22B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$14.44$18.92
Volume (live)
-
Avg. volume (3M)
462.71K

Bausch + Lomb (BLCO) Stock Price & Financial Analysis

Bausch + Lomb Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$17.01 - $17.45
52-Week High$18.92
52-Week Low$14.44
Open$17.12
Volume (last close)426.37K
Average Volume (3M)462.71K
Earnings & Profitability
Revenue (TTM)5.32B
Net Income (TTM)-171.00M
Free Cash Flow (TTM)138.80M
EPS (TTM)−$0.48
Profit Margin-3.21%
Operating Margin7.61%
Return on Equity (ROE)-2.65%
Debt to Equity0.79
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Size & Valuation
Market Cap6.22B
Shares Outstanding357.10M
Price to Sales (P/S)1.17
Price to Book (P/B)0.97
EV/EBITDA14.38
Technical Indicators
50-Day MA$17.12
200-Day MA$16.62
1-Year Change+10.46%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare BLCO with other stocks

Bausch + Lomb at a Glance

As of the Oct 22, 2026 close, Bausch + Lomb (BLCO) has a market capitalization of $6.22B. The stock trades at 1.2× sales. Over the trailing twelve months it lost $171.00M on revenue of $5.32B and generated $138.80M of free cash flow. Revenue grew 8.8% year over year.

As of its latest reported balance sheet, it holds $367.00M in cash and securities against $5.12B of debt, a net debt position of $4.75B.

Bausch + Lomb does not currently pay a dividend.

The share price is up 10.5% over the past year. At $17.43 (the Oct 22, 2026 close) it sits within its 52-week range of $14.44 to $18.91, above its 200-day moving average of $16.62.

Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $20.30, 16.5% above the Oct 22, 2026 close.

Frequently Asked Questions About Bausch + Lomb

What is the current stock price for BLCO?

As of the Oct 22, 2026 close, BLCO stock trades at $17.43. The 52-week range is $14.44–$18.92, with a day range of $17.01–$17.45.

What is the P/E ratio for BLCO?

The P/E ratio (Price-to-Earnings) for BLCO is shown in the Key Statistics section. This valuation metric helps compare Bausch + Lomb Corporation to industry peers.

Does BLCO pay dividends?

Bausch + Lomb does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLCO?

Based on ratings from 13 professional analysts over the last 90 days, the consensus for BLCO is Buy. The average 12-month price target is $20.30, a 16.5% upside from the Oct 22, 2026 close of $17.43.

What is the market cap of BLCO?

As of the Oct 22, 2026 close, Bausch + Lomb's market capitalization is $6.22B, classifying it as a mid-cap company. Bausch + Lomb operates in the Healthcare sector within the Medical Instruments & Supplies industry.